The estimated Net Worth of Lisa Walters Hoffert is at least 516 千$ dollars as of 29 April 2024. Ms Hoffert owns over 1,526 units of Dare Bioscience Inc stock worth over 89,924$ and over the last 7 years she sold DARE stock worth over 26,233$. In addition, she makes 400,325$ as Chief Financial Officer at Dare Bioscience Inc.
Sign up
Ms Hoffert DARE stock SEC Form 4 insiders trading
Ms has made over 6 trades of the Dare Bioscience Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 1,526 units of DARE stock worth 4,975$ on 29 April 2024.
The largest trade she's ever made was exercising 19,319 units of Dare Bioscience Inc stock on 28 April 2023 worth over 62,980$. On average, Ms trades about 2,938 units every 46 days since 2017. As of 29 April 2024 she still owns at least 27,584 units of Dare Bioscience Inc stock.
You can see the complete history of Ms Hoffert stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Lisa Walters-Hoffert biography
Lisa Walters-Hoffert is the Chief Financial Officer at Dare Bioscience Inc.
What is the salary of Ms Hoffert?
As the Chief Financial Officer of Dare Bioscience Inc, the total compensation of Ms Hoffert at Dare Bioscience Inc is 400,325$. There are 1 executives at Dare Bioscience Inc getting paid more, with John A. Fair having the highest compensation of 453,609$.
How old is Ms Hoffert?
Ms Hoffert is 62, she's been the Chief Financial Officer of Dare Bioscience Inc since . There are 3 older and 8 younger executives at Dare Bioscience Inc. The oldest executive at Dare Bioscience Inc is William Rastetter, 72, who is the Independent Chairman of the Board.
What's Ms Hoffert's mailing address?
Lisa's mailing address filed with the SEC is C/O FLUX POWER HOLDINGS, INC., 2685 S. MELROSE DRIVE, VISTA, CA, 92081.
Insiders trading at Dare Bioscience Inc
Over the last 7 years, insiders at Dare Bioscience Inc have traded over 0$ worth of Dare Bioscience Inc stock and bought 594,545 units worth 703,000$ . The most active insiders traders include William H Rastetter、Roger Hawley、Cheryl R Blanchard. On average, Dare Bioscience Inc executives and independent directors trade stock every 152 days with the average trade being worth of 969,110$. The most recent stock trade was executed by Roger Hawley on 11 April 2019, trading 454,545 units of DARE stock currently worth 500,000$.
What does Dare Bioscience Inc do?
daré bioscience (nasdaq: dare) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. we are driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. we are initially focused on the areas of contraception, vaginal health and fertility. our lead product candidate, ovaprene, is a non-hormonal, monthly contraceptive ring that is currently in clinical studies.
What does Dare Bioscience Inc's logo look like?
Complete history of Ms Hoffert stock trades at Dare Bioscience Inc、Flux Power
Dare Bioscience Inc executives and stock owners
Dare Bioscience Inc executives and other stock owners filed with the SEC include:
-
John A. Fair,
Chief Strategy Officer -
Lisa Walters-Hoffert,
Chief Financial Officer -
Robin Steele,
Independent Director -
Gregory Matz,
Independent Director -
Susan Kelley,
Independent Director -
Steve Hall,
Independent Director -
Jessica Grossman,
Independent Director -
Cheryl Blanchard,
Independent Director -
John Fair,
Chief Business Officer -
Jame O'Neill,
Principal Accounting Officer, Controller, Assistant Treasurer -
Lisa Walters-Hoffert,
Chief Financial Officer -
Gregg Beloff,
Principal Financial Officer -
Sabrina Johnson,
President, Chief Executive Officer, Secretary, Director -
William Rastetter,
Independent Chairman of the Board -
John Katsilometes,
Controller -
Mary Jarosz,
Global Head of Regulatory Affairs -
Dr. David Friend,
Chief Scientific Officer -
MarDee J. Haring-Layton,
VP of Accounting & Fin. -
Mark Walters,
VP of Operations -
Roger Hawley,
Director -
Mar Dee Haring Layton,
Chief Accounting Officer -
Sophia Nnenna Ononye Onyia,
Director